Pharmacologic Preservation of Renal Mass and Function in Obstructive Uropathy
- 1 August 1982
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 128 (2) , 418-421
- https://doi.org/10.1016/s0022-5347(17)52950-x
Abstract
Unilateral ureteral obstruction for 1-, 2- and 3-wk intervals in rats resulted in a significant loss of renal mass and function as measured 3 mo. following relief of the obstruction. Inhibition of angiotensin II production by the administration of captopril during the period of obstruction resulted in significant preservation of both renal mass and function. Inhibition of the prostaglandin-thromboxane system with the cyclooxygenase inhibitor, indomethacin, resulted in a lesser degree of preservation of renal function but had no beneficial effect on renal mass. Apparently the renin-angiotensin and prostaglandin-thromboxane systems play a significant role in the loss of renal function from obstructive uropathy and renal function is better maintained if these hormonal systems are pharmacologically inhibited during obstruction.This publication has 7 references indexed in Scilit:
- Obstructive nephropathy in the rat: possible roles for the renin-angiotensin system, prostaglandins, and thromboxanes in postobstructive renal function.Journal of Clinical Investigation, 1980
- Exaggerated prostaglandin biosynthesis and its influence on renal resistance in the isolated hydronephrotic rabbit kidney.Journal of Clinical Investigation, 1977
- Unmasking of thromboxane A2 synthesis by ureteral obstruction in the rabbit kidneyNature, 1977
- Renal function after release of chronic unilateral hydronephrosis in manKidney International, 1975
- Effect of ureteral clamping and increased renal arterial pressure on renin releaseAmerican Journal of Physiology-Legacy Content, 1973
- Recovery Following Complete Chronic Unilateral Ureteral Occlusion: Functional, Radiographic and Pathologic AlterationsJournal of Urology, 1971
- Eine einfache colorimetrische Methode zur Inulinbestimmung für Nieren-Clearance-Untersuchungen bei Stoffwechselgesunden und DiabetikernKlinische Wochenschrift, 1955